Multicenter, Phase 4 Clinical Study from India to Evaluate the Safety and Efficacy of Insulin Glargine 300 U/ml in Insulin-Naïve People with Type 2 Diabetes Uncontrolled on Oral Anti-hyperglycemic Drugs: SAFEGUARD Study
一项来自印度的多中心、4期临床研究(SAFEGUARD研究)旨在评估甘精胰岛素300 U/ml在口服降糖药控制不佳的初治2型糖尿病患者中的安全性和有效性。
期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-025-01736-5
Mohan, Viswanathan; Sethi, Bipin; Jain, Sunil M; Sahay, Rakesh; Ramanathan, Balamurugan; Murthy, Sreenivasa; Singh, Kiran Pal; Menon, Shalini; Gadekar, Arvind; Salvi, Vaibhav; Gandhi, Kedar